The FDA doesn't stop monitoring generic drugs after approval. Using systems like FAERS, Sentinel, and MedWatch, it tracks real-world safety issues, investigates manufacturing changes, and uses AI to catch hidden risks. Here's how it works.
0
Continue Reading
Health and Medicine